3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
6
Other hematologic neoplasm
2
Plasma cell
1
Lymphoid
1
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
2
Carcinoma, Hepatocellular
2
Stomach Neoplasms
1
Pulmonary Embolism
1
Gastrointestinal Stromal Tumors
1
Gallbladder Neoplasms
1
Fibrosis
1
Esophageal Neoplasms
1
Duodenal Neoplasms
1
Cholangiocarcinoma
1
Biliary Tract Neoplasms
1
Interventions
Dalteparin
3
isoquercitrin
1
apixaban
1
abelacimab
1
Tinzaparin
1
MAA868
1
Enoxaparin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pulmonary Embolism
×
apixaban
×
Gastrointestinal
×
Clear all
NCT04191928
2021-12-23
PAP-UP
Thomas Jefferson University
Phase 1
Completed
4 enrolled